AQST — Aquestive Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Aquestive Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	28	27.3	23.9	71.5	121
Net Total Accounts Receivable
Net Total Receivables	12.1	4.7	8.47	7.34	17.8
Total Inventory
Prepaid Expenses
Total Current Assets	47.3	39.9	41	88.2	149
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.78	9.3	9.74	8.98	8.51
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	62	57.1	57.4	101	160
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	22	39.5	18.3	18.9	47.6
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	144	176	164	162	194
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-82.1	-119	-106	-60.2	-33.7
Total Liabilities & Shareholders' Equity	62	57.1	57.4	101	160
Total Common Shares Outstanding